SEC Form 4 insider trading filings tracked in real time from EDGAR

Steinhart Richard I — Chief Financial Officer

Insider trading activity for Steinhart Richard I sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: Chief Financial Officer
  • Company: BioXcel Therapeutics, Inc.
  • Total insider trades: 8
  • Total buy volume: $0
  • Total sell volume: $7K
  • Last trade: Jun 17, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
Jun 15, 2026 Steinhart Richard I BTAI BioXcel Therapeutics, Inc. OTHER 35 N/A
Jun 15, 2026 Steinhart Richard I BTAI BioXcel Therapeutics, Inc. OTHER 35 N/A
May 4, 2026 Steinhart Richard I BTAI BioXcel Therapeutics, Inc. OTHER 17,500 N/A
May 20, 2026 Steinhart Richard I BTAI BioXcel Therapeutics, Inc. SELL 6,845 $7K
May 4, 2026 Steinhart Richard I BTAI BioXcel Therapeutics, Inc. OTHER 17,500 N/A
May 12, 2026 Steinhart Richard I ATOS ATOSSA THERAPEUTICS, INC. OTHER 10,000 N/A
May 1, 2026 Steinhart Richard I BTAI BioXcel Therapeutics, Inc. OTHER 9,000 N/A
May 1, 2026 Steinhart Richard I BTAI BioXcel Therapeutics, Inc. OTHER 9,000 N/A

← All executives · Full trades feed